Recent advances in understanding RAG deficiencies

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• Recombination-activating genes (RAG1/2) are essential for VDJ recombination, initiating lymphocyte receptor formation.
• Nonsense mutations in RAG1/2 lead to severe combined immunodeficiency (SCID), a profound primary immunodeficiency.
• Increasingly recognized are less severe clinical phenotypes associated with RAG gene mutations.

Purpose of the Study:

• To summarize recent findings on RAG1/2 mutations.
• To place genetic and molecular findings of RAG mutations in a clinical context.
• To explore the link between RAG mutations, lymphocyte receptor formation, and autoimmunity.

Main Methods:

• Review of recent genetic and molecular findings related to RAG1/2 mutations.
• Analysis of the correlation between residual RAG protein function and clinical phenotypes.
• Investigation into the impact of RAG mutations on T- and B-lymphocyte receptor development.

Main Results:

• The degree of residual RAG protein function correlates with the severity of clinical phenotypes.
• Non-SCID phenotypes associated with RAG mutations are frequently linked to autoimmunity.
• Understanding RAG mutations provides insight into the development of autoimmunity.

Conclusions:

• RAG1/2 mutations encompass a spectrum of immunodeficiency disorders beyond SCID.
• Residual RAG protein function is a key determinant of clinical presentation.
• RAG mutations offer insights into the pathogenesis of autoimmune diseases.